Three studies show the potential of an artificial pancreas & a less invasive glucose testing device and a 2-drug combo to improve glycemic measures.
Mark L. Fuerst
A prospective study from Spain of over 3600 patients with type 2 diabetes tested the theory that fatty acids protect against diabetic retinopathy.
New studies highlight which T2DM meds help reduce CV risks and, for metformin failure, the benefits of early intervention & a promising drug combo.
To achieve target glucose control, a new study looks at the role of meal composition, including fat and protein, when calculating insulin doses.
Using findings from 100 RCTs, researchers summarize the effects of different dietary fats and carbohydrate on insulin resistance and type 2 diabetes.
A prospective cohort analysis suggests that the length of a woman’s reproductive period has an impact on risk of type 2 diabetes.
A study examined the risk of CV or all-cause mortality associated with glucose-lowering drugs taken alone or in combination for type 2 diabetes.
Why do adolescents with type 1 diabetes fail to meet the international HbA1c treatment target? What can be done to overcome treatment barriers?
Investigators explored the use of bedtime and morning blood glucose values to address postprandial control issues in patients with type 2 diabetes.
Follow-up data from the landmark Diabetes Prevention Study examined the role of physical activity in diabetes prevention.